TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
FBLG

FibroBiologics, Inc.

Healthcare · Biotechnology

1.50$ +3.8% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for FibroBiologics, Inc. (FBLG): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/30/2026.

Next report 10/30/2026
Last report 07/31/2026
Earnings surprise by quarter (%)
Q2 24 · 133.3 % 24 Q3 24 · 88.4 % 24 Q4 24 · 0.0 % 24 Q1 25 · -12.0 % 25 Q2 25 · 0.0 % 25 Q3 25 · -13.0 % 25 Q4 25 · 70.0 % 25 Q1 26 · 1.9 % 26 Q2 26 · 29.0 % 26

EPS estimate beaten

Full history 5 of 9 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/15/2026 FibroBiologics, Inc. (FBLG): Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/24/2026 FibroBiologics, Inc. (FBLG): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/24/2026 FibroBiologics, Inc. (FBLG): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗
  • 07/09/2026 FibroBiologics, Inc. (FBLG): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?